BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6425684)

  • 1. Inhibitory effects of alpha- and beta-naphthoflavones on DMBA-induced anomalies in germ cells assessed by sperm abnormality assay.
    Raj AS; Katz M
    Mutat Res; 1984 Apr; 136(1):81-4. PubMed ID: 6425684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of 7,8-benzoflavone on DMBA- and BaP-induced bone marrow micronuclei in mouse.
    Raj AS; Katz M
    Mutat Res; 1983 Aug; 110(2):337-42. PubMed ID: 6308436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor initiation by 7,12-dimethylbenz[a]anthracene in dermal melanocytes of hamster: inhibition through 7,8-benzoflavone.
    Goerttler K; Loehrke H; Hesse B; Pyerin WG
    Carcinogenesis; 1982; 3(7):791-5. PubMed ID: 6811149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 7,8-benzoflavone on the incidence of skin tumors induced by polycyclic hydrocarbons].
    Linnik AB; Kobliakov VA
    Biull Eksp Biol Med; 1979 May; 87(5):454-5. PubMed ID: 110379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyldibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice.
    Alworth WL; Slaga TJ
    Carcinogenesis; 1985 Apr; 6(4):487-93. PubMed ID: 3921269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of 7, 12-dimethylbenz(a)anthracene(DMBA): on the genesis of DMBA-trans-dihydrodiols and DMBA-7- and 12-methylhydroxylated metabolites.
    Sheikh YM; Cazer FD; Hart RW; Witiak DT
    Biochem Biophys Res Commun; 1980 Apr; 93(3):782-91. PubMed ID: 6770856
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
    Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL
    Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta-naphthoflavone on 7,12-dimethylbenz(a)anthracene metabolism, DNA adduction, and tumorigenicity in rainbow trout.
    Weimer TL; Reddy AP; Harttig U; Alexander D; Stamm SC; Miller MR; Baird W; Hendricks J; Bailey G
    Toxicol Sci; 2000 Oct; 57(2):217-28. PubMed ID: 11006352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of 7,12-dimethylbenz[alpha] anthracene-DNA adducts in 7,8-benzoflavone-treated hamster embryo cells.
    Baird WM; Diamond L
    Chem Biol Interact; 1978 Feb; 20(2):181-90. PubMed ID: 417810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of killing and neoplastic transformation of C3H10T1/2 cells due to 7,12-dimethylbenz[a]anthracene.
    Wells RL; Chen CC; Elkind MM
    Carcinogenesis; 1992 Apr; 13(4):643-9. PubMed ID: 1576717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 7,12-dimethylbenz(alpha)anthracene metabolites on its capacity to induce skin tumors in mice].
    Lopp LKh; Belitskiĭ GA
    Vopr Onkol; 1975; 21(10):50-5. PubMed ID: 810968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone.
    Ladics GS; Kawabata TT; White KL
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the prenatal dimethylbenz[a]anthracene-induced tumour initiation in mice by prior administration of 7,8-benzoflavone.
    Goerttler K; Loehrke H
    Carcinogenesis; 1986 Jul; 7(7):1187-9. PubMed ID: 3087648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine oocyte destruction following intraovarian treatment with 3-methylcholanthrene or 7,12-dimethylbenz(a)anthracene: protection by alpha-naphthoflavone.
    Shiromizu K; Mattison DR
    Teratog Carcinog Mutagen; 1985; 5(6):463-72. PubMed ID: 2874631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dibenz[a,c]anthracene: a potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene.
    Slaga TJ; Viaje A; Buty SG; Bracken WM
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):477-83. PubMed ID: 418469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 7,8-benzoflavone on polycyclic aromatic hydrocarbon dependent mutagenesis and cytotoxicity in a keratinocyte cell-mediated mutation assay.
    Reiners JJ
    Cancer Lett; 1985 Mar; 26(2):215-20. PubMed ID: 3919939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-Hydroxyellipticine: inhibitory effect on skin carcinogenesis induced in Swiss mice by 7,12-dimethylbenz[a]anthracene.
    Lesca P; Mansuy D
    Chem Biol Interact; 1980 May; 30(2):181-7. PubMed ID: 6771025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour initiation in mouse skin by 7,12-dimethylbenz[a]anthracene: irrelevance of systemic activation.
    Pyerin WG; Hecker E
    Cancer Lett; 1980 Feb; 8(4):317-21. PubMed ID: 6768444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the initiation-promotion protocol and by the complete carcinogenesis process.
    Verma AK
    Carcinog Compr Surv; 1982; 7():35-9. PubMed ID: 6802491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of tumor initiating activity and cell mediated mutagenicity of dimethylbenz[a]anthracene by a copper coordination compound.
    Solanki V; Yotti L; Logani MK; Slaga TJ
    Carcinogenesis; 1984 Jan; 5(1):129-31. PubMed ID: 6418405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.